Search results for: 'Managed Security Services Market,'

13 Sep 2016  |  North America  |  Market Research

US Next-generation Sequencing Services Market

$1,000 Genome Pricing and Throughput to Drive More and Larger Sequencing Projects

Infographics

×

The next-generation sequencing (NGS) services market includes all sequencing services conducted with next-generation or third-generation platforms that use newer technology than traditional capillary electrophoresis (CE) sequencing. Services include project scoping, NGS sample preparation tasks (i.e., library prep and target enrichment), and NGS-ba...

This study focuses on clinical lab services in Thailand. A detailed analysis is provided on clinical testing services at public hospital labs and private hospital labs. Specialised labs are integrated into the independent reference labs segment. Certain trends with regard to physician office labs (POLs) in retail clinics have been mentioned in the ...

The Singapore private outpatient diagnostic imaging services market offers insights on diagnostic imaging products such as computed tomography scanners, magnetic resonance imaging, X-ray, mammogram, positron emission tomography, and single-photon emission computed tomography used in polyclinics, private hospitals, and diagnostic centers. Procedura...

19 Aug 2022  |  North America  |  Market Research

Global Antibody Therapeutics Growth Opportunities

The Evolution of Next-generation Immuno-oncology Therapies for Multiple Tumor Antigens is Poised to Drive Market Growth

Infographics

×

Market growth is likely to be fueled by the growing utilization of cost-effective and efficient continuous manufacturing processes and single-use bioreactors for production, which will also reduce the time between development and commercialization. Favorable regulatory reforms in emerging Asian countries are encouraging the manufacture and introduc...

Globally, diagnosis of metabolic diseases such as type 2 diabetes and obesity have increased. Since the COVID-19 pandemic, the global prevalence of obesity has worsened. Obesity is considered a main precursor of diabetes and contributes an estimated 80% to 85% toward the risk of type 2 diabetes. As a result, the financial burden associated with hea...

The United States spends more than $3 trillion—nearly 18% of GDP—on healthcare, a massive sector. Healthcare value chain participants face dynamic environments that several trends impact, including the rise in the aging population (16.9% in 2020); chronic disease burden; regulatory challenges; integration across the care continuum; migration to val...

20 Mar 2019  |  North America  |  Market Research

Growth Opportunities in the North American Clinical Laboratory Services Market, Forecast to 2022

Laboratories Seek Alternate Revenue Streams to Combat Reimbursement Pressure

Infographics

×

Clinical laboratory services represent one of the highest healthcare expenditures in North America, yet the United States and Canada represent different scenarios in the way clinical services are rendered. The market for clinical lab services in Canada was an estimated $10.33 billion in 2017 whereas in the United States it was an estimated $78.33 b...

This industry docket assess Nepal's healthcare market and highlights investment opportunities therein. The country lacks centers of excellence in tertiary care leading to outflow of patients seeking the same. Nepal is currently seeing increasing investment by private and corporate hospital sectors in speciality services like Cardiac Sciences, Neu...

06 Feb 2018  |  Global  |  Market Research

Growth Opportunities in Clinical Trial Data Management and eClinical Solutions Market, Forecast to 2020

Digitization Presents Opportunities for Unified Cloud-based Platform Solutions to Optimize Clinical Trial Workflows

Infographics

×

Key Issues Addressed

The global clinical trial IT market is expected to grow from $2.63 billion in 2016 to $4.29 billion in 2020 at a compound annual growth rate (CAGR) of more than 13.0%. North America will continue to hold the largest market share (by revenue) in 2017, followed by Europe. Increasing clinical trial activities in the emerging Asia-Pacific markets and r...